EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Clinical trials for EXUDATIVE AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new EXUDATIVE AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for EXUDATIVE AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smartphone app could help wet AMD patients space out eye injections
Disease control Not yet recruitingThis study looks at whether a home monitoring app can help people with wet age-related macular degeneration (eAMD) safely extend the time between Aflibercept injections. About 80 adults already receiving this treatment will use the app and have regular eye exams over one to two y…
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Sponsor: Association for Innovation and Biomedical Research on Light and Image • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
AI assistant could sharpen eye injection choices
Diagnosis Not yet recruitingThis trial tests an artificial intelligence system called QiLin that helps doctors decide when to give anti-VEGF injections for retinal diseases like wet AMD, DME, and RVO. About 200 patients who have completed initial treatment will be randomly assigned to have their doctor use …
Matched conditions: EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC